About Wegovy
Wegovy is a weight loss medication that contains the active ingredient semaglutide. It mimics the GLP-1 hormone to help regulate appetite and reduce hunger.
20.5% average weight loss*
Approved for MACE (major adverse cardiovascular events)
Available in 5 strengths to support tailored treatment plans
*Novo Nordisk: Higher dose of Wegovy provided average weight loss of 21% in people with obesity, with a third achieving 25% or more, according to data presented at ADA.






